UK study backs benefits of clinical effectiveness:
This article was originally published in Clinica
Executive Summary
UK trusts and health authorities need to prioritise clinical effectiveness and evidence-based care, concludes a report by Birmingham University's Health Services Management Centre. The study shows that over half of health authorities and a third of trusts are already involved in clinical effectiveness projects, but there is a need for greater progress. Acting on evidence: progress in the NHS is available at £22 for non-members from the NHS Confederation in Birmingham. Fax: +44 121 414 1120.
You may also be interested in...
‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney
HBW Market News: GNC US Chief, Clasado Commercial Head, Barentz Funding
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
US Government Drug Pricing ‘Negotiation:’ Where We Go From Here
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: